ASKA Pharmaceutical Holdings Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ASKA Pharmaceutical Holdings Co Ltd

Watchlist Manager

Watchlist

Price: 1 985 JPY -1.44% Market Closed

Market Cap: ¥57.1B

	ASKA Pharmaceutical Holdings Co Ltd TSE:4886	JP
	Wyndham Hotels & Resorts Inc LSE:0YTR	US
N	NN Group NV OTC:NNGRY	NL
	NextNav Inc NASDAQ:NN	US
	Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	CN
	Supercom Ltd NASDAQ:SPCB	IL
L	Leonardo SpA DUS:FMNB	IT
	Loomis AB STO:LOOMIS	SE
	ZTE Corp SZSE:000063	CN
	Skane mollan AB STO:SKMO	SE
	Carlisle Companies Inc NYSE:CSL	US
	OUTFRONT Media Inc NYSE:OUT	US

Profitability Summary

ASKA Pharmaceutical Holdings Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Sustainable 3Y Average Gross Margin

49%

Gross Margin is Increasing

48% > 49%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

9% > 7%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

10% > 7%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.